Intrinsic Value of S&P & Nasdaq Contact Us

Rh RH NYSE

NYSE • Consumer Cyclical • Specialty Retail • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$281.24
+115.1%
Analyst Price Target
$208.00
+59.1%

Rh (RH) is a Specialty Retail company in the Consumer Cyclical sector, currently trading at $130.77. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of RH = $281.24 (+115.1% from the current price, the stock appears undervalued). Analyst consensus target is RH = $208 (+59.1% upside).

Valuation: RH trades at a trailing Price-to-Earnings (P/E) of 17.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.24.

Financials: revenue is $3.4B, +4.4%/yr average growth. Net income is $125M, growing at +9.7%/yr. Net profit margin is 3.6% (thin). Gross margin is 44.1% (-1.8 pp trend).

Balance sheet: total debt is $4.0B against $61M equity (Debt-to-Equity (D/E) ratio 65.5, leveraged). Current ratio is 1.19 (adequate). Debt-to-assets is 82.1%. Total assets: $4.8B.

Analyst outlook: 18 / 37 analysts rate RH as buy (49%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 17/100 (Fail), Moat 63/100 (Partial), Future 52/100 (Partial), Income 30/100 (Fail).

$208.00
▲ 59.06% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for Rh, the average price target is $208.00, with a high forecast of $283.00, and a low forecast of $160.00.
Highest Price Target
$283.00
Average Price Target
$208.00
Lowest Price Target
$160.00

RH SharesGrow Score Overview

58/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 90/100
Valuation — P/E, PEG, Forward PEG
GROWTH 55/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 63/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RH

VALUE Pass
90/100
RH trades at a trailing Price-to-Earnings (P/E) of 17.6 (S&P 500 average ~25). Forward PEG 0.24 — Peter Lynch undervalued (≤1.0). Trailing PEG 1.32. Analyst consensus target is $208, implying +59.1% from the current price $131. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
55/100
RH: +4.4%/yr revenue is, +9.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
RH: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
17/100
Balance sheet RH: Debt-to-Equity (D/E) ratio 65.5 (leveraged), Current ratio is 1.19 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
63/100
RH: Gross margin is 44.1% (-1.8 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 63/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 18 / 37 analysts rate RH as buy (49%). Analyst consensus target is $208 (+59.1% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
RH: Net profit margin is 3.6%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range106.3-257
Volume797.53K
Avg Volume (30D)1.3M
Market Cap$2.46B
Beta (1Y)2.11
Share Statistics
EPS (TTM)6.65
Shares Outstanding$18.75M
IPO Date2012-11-02
Employees5,690
CEOGary G. Friedman
Financial Highlights & Ratios
Revenue (TTM)$3.44B
Gross Profit$1.52B
EBITDA$387.27M
Net Income$124.79M
Operating Income$387.27M
Total Cash$41.19M
Total Debt$3.97B
Net Debt$3.93B
Total Assets$4.84B
Price / Earnings (P/E)19.7
Price / Sales (P/S)0.72
Analyst Forecast
1Y Price Target$182.50
Target High$283.00
Target Low$160.00
Upside+39.6%
Rating ConsensusBuy
Analysts Covering37
Buy 49% Hold 43% Sell 8%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS74967X1037

Price Chart

RH
Rh  ·  NYSE
Consumer Cyclical • Specialty Retail
106.30 52WK RANGE 257.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message